healthy participants
Conditions
Interventions
Group 1: within-subject design
Day 1: fMRI measurement with intra-nasal saline solution introduced as oxytocin.
Day 2: fMRI measurement with intra-nasal saline solution introduced as saline.
Group 2
Sponsors
Universitätsklinikum Hamburg-Eppendorf
Eligibility
Sex/Gender
All
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: MRI compatible medical information and signed declaration of consent no current intake of prescribed medication no history of psychiatric or neurological disorders
Exclusion criteria
Exclusion criteria: medical information and signed declaration of consent current intake of central nervous system active drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is to examine the effects of positive expectation on mood, reaction time data, and brain responses to non-task related facial expressions. The following data will be collected: Screening: - psychometric questionnaires - cognitive control task Day 1 and day 2: - expectation assessment - Mood reports - fMRI - eye tracking - experience assessment - behavioral data from emotion-interference task. | — |
Secondary
| Measure | Time frame |
|---|---|
| fixation/gaze behaviors during the perceiving of face stimuli | — |
Countries
Germany
Contacts
Public ContactJoshua Baker
Universitätsklinikum Hamburg-Eppendorf
Outcome results
None listed